GeneDx Holdings/$WGS
About GeneDx Holdings
Ticker
Industry
Employees
GeneDx Holdings Metrics
$2.1B
-
-$3.16
2.18
-
Price and volume
Market cap
$2.1B
Beta
2.18
52-week high
$98.87
52-week low
$4.61
Average daily volume
1.1M
Financial strength
Current ratio
2.405
Quick ratio
2.003
Long term debt to equity
54.965
Total debt to equity
56.773
Interest coverage (TTM)
-16.50%
Management effectiveness
Return on assets (TTM)
-8.27%
Return on equity (TTM)
-36.40%
Valuation
Price to revenue (TTM)
7.55
Price to book
10.24
Price to tangible book (TTM)
49.41
Price to free cash flow (TTM)
-33.632
Growth
Revenue change (TTM)
29.41%
Earnings per share change (TTM)
-85.70%
3-year revenue growth (CAGR)
6.97%
3-year earnings per share growth (CAGR)
31.88%
GeneDx Holdings News

GeneDx Holdings Corp. (WGS) Q4 2024 Earnings Call Transcript

Bronstein, Gewirtz & Grossman, LLC Encourages GeneDx Holdings Corp. (WGS) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against GeneDx Holdings Corp. (WGS) and Encourages Investors to Learn More About the Investigation
What’s the current market cap for GeneDx Holdings stock?
What is the P/E ratio for GeneDx Holdings stock?
Does GeneDx Holdings stock pay dividends?
No, GeneDx Holdings (WGS) stock does not pay dividends to its shareholders as of February 18, 2025.
When is the next GeneDx Holdings dividend payment date?
GeneDx Holdings (WGS) stock does not pay dividends to its shareholders.
What is the beta indicator for GeneDx Holdings?
GeneDx Holdings (WGS) has a beta rating of 2.18. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.